| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.09. | Simply Solventless Concentrates Ltd: Simply Solventless targets CCAA exit by November | 1 | Stockwatch | ||
| SIMPLY SOLVENTLESS CONCENTRATES Aktie jetzt für 0€ handeln | |||||
| 21.09. | Simply Solventless Concentrates Ltd.: Simply Solventless Outlines Path to Planned CCAA Exit, Announces Approval of $1.0 Million in Rebates, Settlement of Vendor Take-Back Debt, Revocation of Management Cease Trade Order, and Extension of Stay of CCAA Proc | 323 | Newsfile | Calgary, Alberta--(Newsfile Corp. - September 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce a series of milestones and events that collectively chart the... ► Artikel lesen | |
| 02.09. | Simply Solventless files Q2 financials, expects MCTO revocation | 1 | Investing.com | ||
| 01.09. | Simply Solventless Concentrates Ltd Q1 Loss Narrows | 2 | RTTNews | ||
| 31.08. | Simply Solventless Concentrates Ltd: Simply Solventless files Q1 2026 financials | 1 | Stockwatch | ||
| 28.08. | Simply Solventless Concentrates Ltd: Simply Solventless files 2025 results | 3 | Stockwatch | ||
| 27.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Files 2025 Annual Financials and Provides Updates on Timing of Filing Q1 2026 Financials, Management Cease Trade Order, Private Placement and Debt Settlement | 873 | Newsfile | Not for distribution to U.S. news wire services or for dissemination in the United States.Calgary, Alberta--(Newsfile Corp. - August 27, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH)... ► Artikel lesen | |
| 24.08. | Simply Solventless Concentrates Ltd: Simply Solventless further delays 2025 results filing | 1 | Stockwatch | ||
| 22.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.260 | Newsfile | Calgary, Alberta--(Newsfile Corp. - August 22, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 15.08. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 1 | Stockwatch | ||
| 15.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.492 | Newsfile | Calgary, Alberta--(Newsfile Corp. - August 14, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 01.08. | Simply Solventless Concentrates Ltd: Simply Solventless delays 2025, Q1 2026 results filing | 3 | Stockwatch | ||
| 01.08. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.482 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 31, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 29.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Announces CCAA Court Approvals, Secured Debt Amendments and Conversions to Equity, Strong Initial Humble Retrofit Results, Launch of $1.0M Private Placement of Units, and Executive Retirement | 640 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 28, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") is pleased to announce (i) court approval of the transactions (the... ► Artikel lesen | |
| 22.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 879 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 08.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 592 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 7, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless to file 2025 results July 17 | 1 | Stockwatch | ||
| 06.07. | Simply Solventless Concentrates Ltd: Simply Solventless has no material changes | 2 | Stockwatch | ||
| 04.07. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 1.259 | Newsfile | Calgary, Alberta--(Newsfile Corp. - July 4, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company") provides an update regarding the filing of its audited annual financial... ► Artikel lesen | |
| 19.06. | Simply Solventless Concentrates Ltd.: Simply Solventless Provides Update on Filing of 2025 Annual Financial Statements and Related Management's Discussion and Analysis and Management Cease Trade Order | 756 | Newsfile | Calgary, Alberta--(Newsfile Corp. - June 18, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or the "Company"), provides an update regarding the filing of its audited annual financial... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 44,940 | -1,01 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| MERCK KGAA | 136,90 | +1,82 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| NOVO NORDISK | 33,210 | -0,48 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| ETON PHARMACEUTICALS | 55,42 | 0,00 % | Eton Pharmaceuticals, Inc. - 8-K, Current Report | ||
| SANOFI | 71,08 | -0,03 % | Laufende Fusionskontrollverfahren: Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald) | Datum der Anmeldung:24.09.2026Aktenzeichen:B3-102/26Unternehmen:Sanofi, Paris/FR; Erwerb eines Minderheitsanteils an der Cheplapharm SE (Gemeinschaftsunternehmen mit der Braun Invest Holding GmbH, Greifswald)Produktmärkte:Arzneimittel... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 13,685 | -0,04 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 18,420 | 0,00 % | Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each | WASHINGTON (dpa-AFX) - Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 shares at $18 per share, at the top of the target range. The company... ► Artikel lesen | |
| PFIZER | 24,735 | +0,18 % | Litfulo and tilrekimig data bolster Pfizer's immunology plans | ||
| LB PHARMACEUTICALS | 37,080 | +0,24 % | Needham initiates LB Pharmaceuticals stock with buy rating | ||
| ELI LILLY | 1.019,20 | +0,33 % | Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma | ||
| BIOHAVEN | 12,870 | 0,00 % | Biohaven Ltd.: Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026 | Oral presentation selected: Phase 1 findings from the ongoing BHV1530-101 study will be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium on... ► Artikel lesen | |
| SCHOTT PHARMA | 24,550 | +0,82 % | Aktien Frankfurt: Dax macht Verluste wett - Ölpreis und Anleiherenditen im Fokus | FRANKFURT (dpa-AFX) - Der deutsche Aktienmarkt hat sich am Dienstagnachmittag von seinen Anfangsverlusten vollständig erholt. Eine leichte Entspannung bei den Ölpreisen und bei den Anleiherenditen... ► Artikel lesen | |
| NOVARTIS | 124,98 | -0,14 % | CH-Verlauf: Fester dank Novartis und Nestlé, Roche fallen ab | Zürich - Der Schweizer Aktienmarkt ist mit Schwung in die neue Woche gestartet und hat die Marke bei 14'000 klar zurückerobert. In der Folge konnte er indes dieses Niveau nicht ganz halten. Gestützt... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,555 | +0,11 % | Aquestive appoints Rich Daly to board of directors | ||
| GILEAD SCIENCES | 128,68 | +0,09 % | Assembly Biosciences: Herpes-Countdown mit Gilead |